Equities Research Analysts’ updated eps estimates for Wednesday, September 18th:
The Goldman Sachs Group, Inc. began coverage on shares of Aviva (LON:AV). The Goldman Sachs Group, Inc. issued a buy rating on the stock.
Corpay (NYSE:CPAY) had its price target increased by Jefferies Financial Group Inc. from $350.00 to $375.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Ferguson (NASDAQ:FERG) had its target price increased by Citigroup Inc. from $203.00 to $221.00. Citigroup Inc. currently has a neutral rating on the stock.
Ferguson (NASDAQ:FERG) had its price target trimmed by Wells Fargo & Company from $250.00 to $225.00. The firm currently has an overweight rating on the stock.
InterContinental Hotels Group (LON:IHG) was upgraded by analysts at The Goldman Sachs Group, Inc. to a buy rating.
Kingfisher (LON:KGF) had its target price increased by Deutsche Bank Aktiengesellschaft from GBX 310 ($4.10) to GBX 350 ($4.62). Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
LKQ (NASDAQ:LKQ) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $60.00 target price on the stock.
Marshalls (LON:MSLH) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a GBX 370 ($4.89) target price on the stock.
National Storage Affiliates Trust (NYSE:NSA) had its price target increased by Jefferies Financial Group Inc. from $47.00 to $54.00. The firm currently has a buy rating on the stock.
Phoenix Group (LON:PHNX) had its target price raised by JPMorgan Chase & Co. from GBX 505 ($6.67) to GBX 510 ($6.74). JPMorgan Chase & Co. currently has an underweight rating on the stock.
Phoenix Group (LON:PHNX) had its sell rating reissued by analysts at The Goldman Sachs Group, Inc..
Public Storage (NYSE:PSA) had its target price raised by Jefferies Financial Group Inc. from $360.00 to $422.00. The firm currently has a buy rating on the stock.
Whitbread (LON:WTB) was downgraded by analysts at The Goldman Sachs Group, Inc. to a neutral rating.
Zevra Therapeutics (NASDAQ:ZVRA) had its target price reduced by Canaccord Genuity Group Inc. from $24.00 to $22.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Receive News & Ratings for Aviva plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva plc and related companies with MarketBeat.com's FREE daily email newsletter.